Oral contraceptives reduce lamotrigine plasma levels
- 26 August 2003
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 61 (4) , 570-571
- https://doi.org/10.1212/01.wnl.0000076485.09353.7a
Abstract
The mean steady-state plasma concentration of lamotrigine (LTG) was 13 μmol/L in 22 women taking LTG in combination oral contraceptives (OC) compared with 28 μmol/L among 30 women on LTG who did not take OC (p < 0.0001). The LTG dose/body weight/plasma concentration was 2.1 L/kg/day in women on OC compared with 0.8 L/kg/day in women without OC (p < 0.0001), indicating that LTG plasma levels are reduced by >50% during OC co-medication. It is advisable to monitor LTG plasma levels in conjunction with initiation or withdrawal of OC in women on LTG therapy.Keywords
This publication has 9 references indexed in Scilit:
- Lamotrigine clearance during pregnancyNeurology, 2002
- Therapeutic Drug Monitoring of LamotrigineAnnals of Pharmacotherapy, 2002
- Lamotrigine plasma levels reduced by oral contraceptivesEpilepsy Research, 2001
- Lamotrigine in Pregnancy: Pharmacokinetics During Delivery, in the Neonate, and During LactationEpilepsia, 2000
- Therapeutic monitoring of the new antiepileptic drugsEuropean Journal of Clinical Pharmacology, 2000
- Liquid chromatographic determination of plasma lamotrigine in pediatric samplesJournal of Pharmaceutical and Biomedical Analysis, 1996
- A Liquid Chromatographic Assay Using a High-Speed Column for the Determination of Lamotrigine, a New Antiepileptic Drug, in Human PlasmaTherapeutic Drug Monitoring, 1992
- Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination.British Journal of Clinical Pharmacology, 1984
- Influence of sex and oral contraceptive steroids on paracetamol metabolism.British Journal of Clinical Pharmacology, 1983